Evoke Pharma Inc. (NASDAQ: EVOK) Stock Information | RedChip

Evoke Pharma Inc. (NASDAQ: EVOK) Listen to this Section


$5.61
+0.0550 ( +0.99% ) 5.3K

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Market Data


Open


$5.61

Previous close


$5.55

Volume


5.3K

Market cap


$4.23M

Day range


$5.55 - $5.81

52 week range


$4.32 - $18.60

Insider Ownership Transactions

Total Amount Purchased: -175,672.00 | $ -984,641.56

Date Type Amount Purchased Purchaser
2024-08-08 Sale -64840.00 D'Onofrio Matthew J
2024-08-08 Sale -17291.00 CARLSON MARILYN R.
2024-08-08 Sale -17291.00 Kowieski Mark
2024-05-24 Sale -14625.00 Brady Todd C
2024-05-24 Sale -14250.00 WIDDER KENNETH J
2024-05-24 Sale -15000.00 REED VICKIE S
2024-05-24 Sale -17750.00 GARNER CAM L
2024-05-24 Sale -14625.00 Hill Malcolm R

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 11 Aug 16, 2024
10-q Quarterly Reports 42 Aug 13, 2024
8-k 8K-related 13 Aug 13, 2024
4 Insider transactions 1 Aug 08, 2024
4 Insider transactions 1 Aug 08, 2024
4 Insider transactions 1 Aug 08, 2024
8-k 8K-related 12 Aug 01, 2024
8-k 8K-related 12 Jun 20, 2024
8-k 8K-related 11 Jun 07, 2024
3 Insider transactions 1 May 30, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.